Advanced LNP Formulation & Screening – Unchained Labs Sunshine
Advanced LNP Formulation & Screening – Unchained Labs Sunshine
Precision microfluidics for non-viral gene delivery, cell therapies, and targeted therapeutics.
At ImmunitasBio, we bridge the gap between early-stage discovery and clinical translation. Utilizing state-of-the-art automated microfluidic systems, we provide bespoke Lipid Nanoparticle (LNP) formulation services engineered for stability, precision, and scalability.
Core Capabilities:
- High-Throughput Optimization: Rapidly determine the ideal lipid-to-payload ratio. We screen up to 96 unique LNP formulations in a single run to dial in the exact particle size, PDI, and encapsulation efficiency your therapy requires.
- Gene & Cell Therapy Vectors: Securely encapsulate and protect fragile nucleic acids (mRNA, siRNA, DNA) to ensure structural integrity and efficient target-cell transfection.
- Targeted Drug Delivery: Formulate LNPs to carry difficult-to-solubilize small molecules and APIs, improving bioavailability and controlling release kinetics.
- Seamless Scale-Up: Transition confidently from pre-clinical research to clinical production. Our microliter-scale optimizations are designed to scale linearly without sacrificing particle integrity.
The ImmunitasBio Advantage:
Formulation is only half the battle. We pair advanced LNP screening with our comprehensive suite of in-house immunodiagnostic services. Once your nanoparticles are formulated, we immediately validate their biological efficacy and cellular uptake using deep T-cell phenotyping, ELISPOT assays, and digital PCR.
You receive a functionally validated therapeutic candidate, all under one roof.
